文献速递肝胆胰外科围术期管理与 ERAS

原发性醛固酮增多症合并皮质醇增多症患者肾上腺切除术后结局分析

Adrenalectomy patients with mixed primary aldosteronism and hypercortisolism: An analysis of outcomes following surgery at a single institution.
PubMed 文献 · Surgery · 2025-11-18

单中心回顾性研究纳入94例因原发性醛固酮增多症行单侧肾上腺切除术的成人,28例(29.8%)为混合型原发性醛固酮增多症/皮质醇增多症。

要点

  • 所有原发性醛固酮增多症患者术前应行地塞米松抑制试验筛查合并皮质醇增多症。
  • 混合型患者术后需糖皮质激素替代的风险显著高于单纯原发性醛固酮增多症。
  • 混合型患者术后临床缓解率较低,需合理预期手术结局。

核心结论

  • 混合型原发性醛固酮增多症/皮质醇增多症患者术后更可能需要糖皮质激素替代,且部分或完全临床缓解的可能性更低。

研究设计与样本

  • 单中心回顾性队列研究,纳入94例因原发性醛固酮增多症行单侧肾上腺切除术的成人,排除未行术前皮质醇增多症检测者。

主要发现

  • 94例手术患者中28例(29.8%)为混合型原发性醛固酮增多症/皮质醇增多症。

关键数值与推荐

  • 采用原发性醛固酮增多症手术结局(PASO)标准评估临床和生化成功。

临床怎么用

  • 建议对所有原发性醛固酮增多症患者术前进行地塞米松抑制试验,以指导围术期管理、识别术后肾上腺功能不全风险并合理设定手术结局预期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A subset of patients with primary aldosteronism have clinical and/or biochemical evidence of hypercortisolism, suggesting excess co-secretion of both aldosterone and cortisol (mixed primary aldosteronism/hypercortisolism). This study examined patients with mixed primary aldosteronism/hypercortisolism and compared their outcomes following adrenalectomy to those of patients with primary aldosteronism only. METHODS: This was a retrospective review of adults who underwent unilateral adrenalectomy at a single institution for primary aldosteronism. Patients were excluded if they did not undergo preoperative testing for hypercortisolism. Demographics, comorbidities, nodule size, adrenal venous sampling, laterality, and perioperative steroid usage were assessed to compare patients with mixed primary aldosteronism/hypercortisolism to those with primary aldosteronism only. The Primary Aldosteronism Surgical Outcome criteria were applied to assess clinical and biochemical success. RESULTS: Of 94 patients who underwent surgery, 28 (29.8%) had mixed primary aldosteronism/hypercortisolism. Patients with mixed primary aldosteronism/hypercortisolism tended to be older than those with primary aldosteronism only. Patients with mixed primary aldosteronism/hypercortisolism had larger adrenal glands on imaging (median 2.4 cm vs 1.3 cm, P = .002) and had higher rates of discharge on glucocorticoid replacement therapy (35.7% vs 3.0%, P < .001). On long-term follow-up, mixed primary aldosteronism/hypercortisolism patients were more likely to remain hypertensive and/or on the same number of antihypertensive medications as before surgery (21.4% vs 3.0%, P = .014). CONCLUSION: Patients with mixed primary aldosteronism/hypercortisolism were more likely to need postoperative glucocorticoid replacement and less likely to have a partial or complete clinical response to surgery. This highlights the importance of preoperative dexamethasone suppression test in all patients with primary aldosteronism to guide perioperative management, identify those at risk for postoperative adrenal insufficiency, and appropriately frame outcomes.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Taylor GA, Allen M, Lisevick Kumar A, et al. Adrenalectomy patients with mixed primary aldosteronism and hypercortisolism: An analysis of outcomes following surgery at a single institution. Surgery. 2025. PMID: 41371823. doi:10.1016/j.surg.2025.109855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。